Cigna ($CI) delivered its fourth consecutive quarter of strong revenue and earnings per share (EPS) beats, with Q4 revenue rising 6% year-over-year to $45.3 billion and adjusted EPS increasing 15% to $4.96. Despite this impressive performance, the market remains skeptical, with $CI stock trading at a significant discount to its sector peers, presenting a potential buying opportunity for investors.
Cigna’s repeated earnings beats can be attributed to its successful strategy of expanding its healthcare services and improving operational efficiency. The company’s Cigna health insurance business has been a key driver of growth, with enrollment increasing 4% year-over-year to 18.9 million members. Additionally, Cigna’s Evernorth health services business has seen significant growth, with revenue increasing 10% year-over-year to $34.5 billion.
The market’s skepticism towards $CI stock can be attributed to concerns over the company’s high debt levels and the potential impact of regulatory changes on its business. However, Cigna has been actively working to reduce its debt, with net debt decreasing 12% year-over-year to $26.4 billion. Furthermore, the company’s diversified business model, which includes both health insurance and health services, provides a degree of protection against regulatory risks.
The following table highlights Cigna’s key financial metrics:
| Metric | Q4 2022 | Q4 2021 |
|---|---|---|
| Revenue | $45.3 billion | $42.7 billion |
| Adjusted EPS | $4.96 | $4.30 |
| Net Debt | $26.4 billion | $30.1 billion |
Looking ahead, Cigna is well-positioned to continue its growth trajectory, driven by its expanding healthcare services business and improving operational efficiency. The company’s diversified business model and strong financial position also provide a degree of protection against regulatory risks and economic uncertainty. As such, $CI stock presents a compelling buying opportunity for investors seeking a stable and growth-oriented investment in the healthcare sector.
⚡ Why it matters: Cigna’s repeated earnings beats and discounted valuation make it an attractive investment opportunity in the healthcare sector. The company’s strong financial position and diversified business model provide a degree of protection against regulatory risks and economic uncertainty.
📊 By the numbers:
Q4 revenue: $45.3 billion
Adjusted EPS: $4.96
Net debt: $26.4 billion
Enrollment: 18.9 million members
🔗 Source: [Cigna Q4 2022 earnings release]
